Main Conference Day One

9:00 AM - 9:45 AM BREAKING NEWS INTERACTIVE KEYNOTE: Recap Discussion on Pressing DSCSA Updates Coming Out of the FDA Workshops

Matt Sample, Senior Director of Secure Supply Chain, AmerisourceBergen Corporation Mary Anne Anderson, Director, Program Management, Fresenius Kabi USA, LLC

img

Matt Sample

Senior Director of Secure Supply Chain
AmerisourceBergen Corporation

Mary Anne Anderson

Director, Program Management
Fresenius Kabi USA, LLC

img

Dave Mason

Global Program Serialization Lead
Sandoz
img

Mark Hendrickson

Senior Director of Sciences and Regulatory Affairs
Association of Accessible Medicines
img

Kevan MacKenzie

Director of Serialization Technologies
McKesson
Group 1: Grandfathering
Group 2: Resource Challenges
Group 3: Software Updates


Mary Anne Anderson

Director, Program Management
Fresenius Kabi USA, LLC
img

Earlene Gibbons

Senior Director of Operational Technology
United Therapeutics

img

Matt Sample

Senior Director of Supply Chain
AmerisourceBergen Corporation
img

Travis Buel

Director Manufacturing & Packaging Engineer
Iroko Pharmaceuticals
img

Michael Rowe

Manager-Operations Technology (Track & Trace)
Cardinal Health
Group 1: Manufacturers
Group 2: Wholesalers
Group 3: Dispensers

img

Scott Hatakeyama

Director - Buy to Pay
Kaiser Permanente
img

Senthil Rajaratnam

Affiliate Relations Manager, Global Serialization Program
Eli Lilly & Company
img

Michael Rowe

Manager-Operations Technology (Track & Trace)
Cardinal Health

img

Scott Hatakeyama

Director - Buy to Pay
Kaiser Permanente
img

Senthil Rajaratnam

Affiliate Relations Manager, Global Serialization Program
Eli Lilly & Company
img

Andy Meyer

Serialization Lead & Senior Systems Analyst
North Carolina Mutual Wholesale Drug Company

3:45 PM - 4:30 PM PANEL DISCUSSION: Maintaining Data Integrity & Accuracy in a Post-Serialized Supply Chain

Chris Hobby, Director of IT, Xttrium Laboratories, Inc.

img

Chris Hobby

Director of IT
Xttrium Laboratories, Inc.

4:30 PM - 5:15 PM END OF DAY KEYNOTE: Breaking the Counterfeits- How Pharma can Continue to Outsmart Counterfeiters through Serialization and Increased Vigilance

J. Aaron Graham, Executive Director – Brand Safety & Security, Boehringer Ingelheim Pharmaceuticals, Inc.

img

J. Aaron Graham

Executive Director – Brand Safety & Security
Boehringer Ingelheim Pharmaceuticals, Inc.